vVARDIS
About vVARDIS
vVARDIS is a Medical Devices startup based in Zug, Switzerlandsince 2019. The company reached Growth stage in February 2025 with a $35M round led by OrbiMed. vVARDIS's investor base includes 2 institutional funds, with Apollo Global Management leading the most recent equity round.
vVARDIS is a Swiss dental medtech company pioneering non-invasive, drill-free treatment for early-stage tooth decay. Its flagship Curodont product suite uses patented biomimetic peptide-based formulations that penetrate enamel and work with the body's natural saliva minerals to repair teeth from within, eliminating the need for drilling. Founded in 2019 by dentist sisters Dr. Haley and Dr. Goly Abivardi in Zug, Switzerland, vVARDIS has treated approximately 3 million teeth since launching in the US and is present in nearly 20% of US general dental practices. The company achieved unicorn status in April 2026 with a strategic minority investment from Apollo-managed funds.
vVARDIS Funding Rounds Timeline
3 rounds · since 2019
| Round | Date | Amount | Valuation | Lead investor | Co-investors |
|---|---|---|---|---|---|
| Series B | February 2025 | $35M | — | OrbiMed | — |
| Series C | July 2025 | $50M | — | OrbiMed | — |
| Growth | April 2026 | Undisclosed | $1B | Apollo Global Management | — |
Investors in vVARDIS
2 institutional investors across 3 rounds
Lead investors
Recent news about vVARDIS
Questions about vVARDIS
How much has vVARDIS raised?
vVARDIS has raised null across 3 funding rounds since 2019.
Who are the investors of vVARDIS?
vVARDIS's investors include Apollo Global Management, OrbiMed.
When was vVARDIS's last funding round?
vVARDIS's most recent round was a $35M Series B in February 2025, led by OrbiMed.
What is vVARDIS's valuation?
vVARDIS reached a $1B valuation (unicorn status) with its Series B round in February 2025.
Where is vVARDIS headquartered?
vVARDIS is headquartered in Zug, Switzerland, and was founded in 2019 by Dr. Haley Abivardi, Dr. Goly Abivardi.